DIVA Laboratories

DIVA Laboratories FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of DIVA Laboratories (4153.TWO) as of Oct 17, 2026 is 21.83 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 129.20 % — a change of -83.10% (lower).

FCF Conversion

21.83 %

YoY

-83.10%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of DIVA Laboratories is 2025 21.83 % . FCF Conversion Rate (FCF/EBITDA) of DIVA Laboratories was 2024 129.20 % . It decreases by -83.10% lower compared to the previous year.

The DIVA Laboratories FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
123.30 TWD
Jan 1, 2019
71.14 TWD
Jan 1, 2020
-220.49 TWD
Jan 1, 2021
-110.91 TWD
Jan 1, 2022
124.38 TWD
Jan 1, 2023
333.11 TWD
Jan 1, 2024
129.20 TWD
Jan 1, 2025
21.83 TWD
The DIVA Laboratories FCF Conversion history
YEARFCF ConversionYoY
21.83 %-83.10%
129.20 %-61.22%
333.11 %+167.81%
124.38 %-212.15%
-110.91 %-49.70%
-220.49 %-409.95%
71.14 %-42.30%
123.30 %-1,270.56%
-10.53 %-111.50%
91.56 %-20.17%
114.70 %-1,306.95%
-9.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

DIVA Laboratories Stock analysis

What does DIVA Laboratories do? DIVA Laboratories Ltd., headquartered in Taipei, Taiwan, operates in the Information Technology sector, specializing in Electrical Equipment. The company designs and manufactures precision displays for medical imaging systems, including PACS, endoscopic devices, and ultrasound equipment, as well as TFT LCD products for touch screen systems and Panel PCs. Listed on 11 October 2010, DIVA employs 133 people and serves global markets with its display solutions. DIVA Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DIVA Laboratories stock

FCF Conversion Rate (FCF/EBITDA) of DIVA Laboratories is 21.83 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of DIVA Laboratories changed from 129.20 % to 21.83 %, representing a -83.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) DIVA Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s DIVA Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — DIVA Laboratories

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — DIVA Laboratories